SCHEMBL10067941

SCHEMBL10067941

CCC(=O)[C@@H]1C[C@@H](O)CN1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 4/20 0.40
DPP8 Q6V1X1 4/20 0.40
DPP9 Q86TI2 4/20 0.40
SMYD3 Q9H7B4 1/20 0.38
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
ALOX15 P16050 1/20 0.33
CYP2C19 P33261 1/20 0.33
SLC1A3 P43003 1/20 0.33
SLC1A2 P43004 1/20 0.33
SLC1A1 P43005 1/20 0.33
CTSC P53634 3/20 0.32
CHRNB2 P17787 2/20 0.32
CHRNA3 P32297 2/20 0.32
CHRNA4 P43681 2/20 0.32
CHRNB4 P30926 1/20 0.32
CHRNA7 P36544 1/20 0.32
CHRNB3 Q05901 1/20 0.31
CHRNA6 Q15825 1/20 0.31
ARG1 P05089 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5597343 0.82
Propane SCHEMBL28273128 0.79 CYP2D6 (0.52) DPP4DPP8DPP9SMYD3CYP1A2
SCHEMBL26575461 0.79 CTSC (0.37) CYP1A2CYP2D6ALOX15CYP2C19SLC1A3
SCHEMBL19374366 0.79 CTSC (0.37) CYP1A2CYP2D6ALOX15CYP2C19SLC1A3
SCHEMBL13188074 0.79 CTSC (0.37) CYP1A2CYP2D6ALOX15CYP2C19SLC1A3
SCHEMBL16083485 0.78 DPP8 (0.41) DPP4DPP8DPP9CYP1A2CYP2D6
Propane SCHEMBL28234826 0.78 SMYD3 (0.40) DPP4DPP8DPP9SMYD3CYP1A2
SCHEMBL12281477 0.78 CTSC (0.41) SMYD3CYP1A2CYP2D6ALOX15CYP2C19
SCHEMBL8916458 0.78 CTSC (0.41) SMYD3CYP1A2CYP2D6ALOX15CYP2C19
Alcohol SCHEMBL28063732 0.78 CYP2D6 (0.50) DPP4DPP8DPP9SMYD3CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120077711-A1 Novel Ligands and Libraries of Ligands SUNESIS PHARMACEUTICALS, INC. (US) 2012-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120077711-A1 Novel Ligands and Libraries of Ligands LSS, ABCG2, SELL DPP4 3178/4885DPP8 2940/4885DPP9 2628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.